Cargando…

A Network Analysis of Multiple Myeloma Related Gene Signatures

Multiple myeloma (MM) is the second most prevalent hematological cancer. MM is a complex and heterogeneous disease, and thus, it is essential to leverage omics data from large MM cohorts to understand the molecular mechanisms underlying MM tumorigenesis, progression, and drug responses, which may ai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yu, Yu, Haocheng, Yoo, Seungyeul, Lee, Eunjee, Laganà, Alessandro, Parekh, Samir, Schadt, Eric E., Wang, Li, Zhu, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6827160/ https://www.ncbi.nlm.nih.gov/pubmed/31569720 http://dx.doi.org/10.3390/cancers11101452

Ejemplares similares

Integrating epigenetic data into molecular casual networks
por: Yoo, Seungyeul, et al.
Publicado: (2014)

A probabilistic multi-omics data matching method for detecting sample errors in integrative analysis
por: Lee, Eunjee, et al.
Publicado: (2019)

MODMatcher: Multi-Omics Data Matcher for Integrative Genomic Analysis
por: Yoo, Seungyeul, et al.
Publicado: (2014)

Identification of a novel cuproptosis‐related gene signature for multiple myeloma diagnosis
por: Zhu, Yidong, et al.
Publicado: (2023)

A pilot systematic genomic comparison of recurrence risks of hepatitis B virus-associated hepatocellular carcinoma with low- and high-degree liver fibrosis
por: Yoo, Seungyeul, et al.
Publicado: (2017)

Temporal genetic association and temporal genetic causality methods for dissecting complex networks
por: Lin, Luan, et al.
Publicado: (2018)

Using Prognosis-Related Gene Expression Signature and Connectivity Map for Personalized Drug Repositioning in Multiple Myeloma
por: Zhu, Fang-xiao, et al.
Publicado: (2019)

Integrative network analysis of early-stage lung adenocarcinoma identifies aurora kinase inhibition as interceptor of invasion and progression
por: Yoo, Seungyeul, et al.
Publicado: (2022)

Identification and validation of a novel cuproptosis-related gene signature in multiple myeloma
por: Zhang, Bingxin, et al.
Publicado: (2023)

A novel glycolysis-related gene signature for predicting the prognosis of multiple myeloma
por: Zhang, Bingxin, et al.
Publicado: (2023)

An emerging prognosis prediction model for multiple myeloma: Hypoxia-immune related microenvironmental gene signature
por: Yu, Zhengyu, et al.
Publicado: (2022)

Patient similarity network of newly diagnosed multiple myeloma identifies patient subgroups with distinct genetic features and clinical implications
por: Bhalla, Sherry, et al.
Publicado: (2021)

A novel ferroptosis-related gene signature for predicting prognosis in multiple myeloma
por: Gao, Dandan, et al.
Publicado: (2023)

Identification of Let-7 miRNA Activity as a Prognostic Biomarker of SHH Medulloblastoma
por: Westphal, Maximillian S., et al.
Publicado: (2021)

MAGE-A inhibit apoptosis and promote proliferation in multiple myeloma through regulation of BIM and p21(Cip1)
por: Mei, Anna Huo-Chang, et al.
Publicado: (2020)

Identification of a cholesterol metabolism-related prognostic signature for multiple myeloma
por: Zhao, Na, et al.
Publicado: (2023)

Development and Validation of a 9-Gene Prognostic Signature in Patients With Multiple Myeloma
por: Liu, Xiao-Ping, et al.
Publicado: (2019)

Precision Medicine for Relapsed Multiple Myeloma on the Basis of an Integrative Multiomics Approach
por: Laganà, Alessandro, et al.
Publicado: (2018)

A gene signature can predict risk of MGUS progressing to multiple myeloma
por: Sun, Fumou, et al.
Publicado: (2023)

Integrative Analysis of DNA Methylation and Gene Expression Data Identifies EPAS1 as a Key Regulator of COPD
por: Yoo, Seungyeul, et al.
Publicado: (2015)

A deep attention LSTM embedded aggregation network for multiple histopathological images
por: Kim, Sunghun, et al.
Publicado: (2023)

An Unusual Presentation of Multiple Myeloma
por: Parekh, Ishan, et al.
Publicado: (2022)

Simultaneous Clustering of Multiple Gene Expression and Physical Interaction Datasets
por: Narayanan, Manikandan, et al.
Publicado: (2010)

Triple MAPK inhibition salvaged a relapsed post-BCMA CAR-T cell therapy multiple myeloma patient with a BRAF V600E subclonal mutation
por: Elnaggar, Muhammad, et al.
Publicado: (2022)

Characterization and application of a lactate and branched chain amino acid metabolism related gene signature in a prognosis risk model for multiple myeloma
por: Yu, Zhengyu, et al.
Publicado: (2023)

A Cancer-Related microRNA Signature Shows Biomarker Utility in Multiple Myeloma
por: Papanota, Aristea-Maria, et al.
Publicado: (2021)

Integrative Analysis of a Pyroptosis-Related Signature of Clinical and Biological Value in Multiple Myeloma
por: Wang, Huizhong, et al.
Publicado: (2022)

Integrative analysis of the prognostic value and immune microenvironment of mitophagy-related signature for multiple myeloma
por: Jia, Yachun, et al.
Publicado: (2023)

Correction: Triple MAPK inhibition salvaged a relapsed post-BCMA CAR-T cell therapy multiple myeloma patient with a BRAF V600E subclonal mutation
por: Elnaggar, Muhammad, et al.
Publicado: (2023)

A reference profile-free deconvolution method to infer cancer cell-intrinsic subtypes and tumor-type-specific stromal profiles
por: Wang, Li, et al.
Publicado: (2020)

Subcutaneous daratumumab and hyaluronidase-fihj in newly diagnosed or relapsed/refractory multiple myeloma
por: Sanchez, Larysa, et al.
Publicado: (2021)

A gene expression inflammatory signature specifically predicts multiple myeloma evolution and patients survival
por: Botta, C, et al.
Publicado: (2016)

A gene expression signature distinguishes innate response and resistance to proteasome inhibitors in multiple myeloma
por: Mitra, A K, et al.
Publicado: (2017)

A bendamustine resistance gene signature in diffuse large B-cell lymphoma and multiple myeloma
por: Issa, Issa Ismail, et al.
Publicado: (2021)

Integrative gene network analysis identifies key signatures, intrinsic networks and host factors for influenza virus A infections
por: Forst, Christian V., et al.
Publicado: (2017)

MM-239: A Tertiary Center Experience of Multiple Myeloma Patients with COVID-19: Lessons Learned and the Path Forward
por: Wang, Bo, et al.
Publicado: (2020)

Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network
por: Ludwig, Heinz, et al.
Publicado: (2020)

European Myeloma Network perspective on CAR T-cell therapies for multiple myeloma
por: Bruno, Benedetto, et al.
Publicado: (2021)

Bone Marrow Stroma-Induced Transcriptome and Regulome Signatures of Multiple Myeloma
por: Dziadowicz, Sebastian A., et al.
Publicado: (2022)

Comprehensive analysis of ferroptosis-related genes in immune infiltration and prognosis in multiple myeloma
por: Wang, Quanqiang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ke2s0cfjo3m3lbt8vlgm8cin6i